Related references
Note: Only part of the references are listed.Through the Gatekeeper Door: Exploiting the Active Kinase Conformation
Fabio Zuccotto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Non-hinge-bindingpyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors
Dan M. Berger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Thomas O'Hare et al.
CANCER CELL (2009)
Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
Markus A. Seeliger et al.
CANCER RESEARCH (2009)
Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180-086
J. Araujo et al.
EJC SUPPLEMENTS (2009)
Conformational Sampling with Stochastic Proximity Embedding and Self-Organizing Superimposition: Establishing Reasonable Parameters for Their Practical Use
Gary Tresadern et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information
Johannes Kirchmair et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Conformational Analysis of Macrocycles: Finding What Common Search Methods Miss
Pascal Bonnet et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology
Lars Neumann et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc
Matthaeus Getlik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2
Qing-Qing Xie et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2009)
Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors
Jeffrey R. Simard et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Optimal assignment methods for ligand-based virtual screening
Andreas Jahn et al.
JOURNAL OF CHEMINFORMATICS (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
N-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck:: Structure, synthesis and SAR
Holly L. Deak et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Discovery of a potent and selective Aurora kinase inhibitor
Johan D. Oslob et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition
A. C. Backes et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition
A. C. Backes et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States
Irina Kufareva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A pharmacophore map of small molecule protein kinase inhibitors
Malcolm J. McGregor
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Fast and efficient in silico 3D screening: Toward maximum computational efficiency of pharmacophore-based and shape-based approaches
Johannes Kirchmair et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Design, synthesis, and evaluation of orally active Benzimidazoles and Benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
Michele H. Potashman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Conformational sampling of bioactive molecules: A comparative study
Dimitris K. Agrafiotis et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine tie-2 kinase inhibitor
Brian L. Hodous et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Benchmarking sets for molecular docking
Niu Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A general strategy for creating Inactive-conformation Abl inhibitors
Barun Okram et al.
CHEMISTRY & BIOLOGY (2006)
Rational design of inhibitors that bind to inactive kinase conformations
Y Liu et al.
NATURE CHEMICAL BIOLOGY (2006)
Conformational boosting
Dimitris K. Agrafiotis et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2006)
Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors
Y Miyazaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction
TS Rush et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
E Weisberg et al.
CANCER CELL (2005)
Identification of novel p38α MAP kinase inhibitors using fragment-based lead generation
AL Gill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Protein kinase inhibitors: Insights into drug design from structure
MEM Noble et al.
SCIENCE (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Structural biology in drug design: selective protein kinase inhibitors
G Scapin
DRUG DISCOVERY TODAY (2002)
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
C Pargellis et al.
NATURE STRUCTURAL BIOLOGY (2002)
Share Paper
